ESC Premium Access

RHAPSODY: a pivotal phase 3 trial to assess efficacy and safety of rilonacept, an interleukin 1 alpha and beta blocker, in patients with recurrent pericarditis

Congress Presentation

About the speaker

Professor Massimo Imazio

San Giovanni Battista – Molinette Hospital, Turin (Italy)
18 presentations
5 followers

11 more presentations in this session

Micro and macrovascular damage across the glycemic spectrum among women and men from general population

Speaker: Associate Professor M. Kavousi (Rotterdam, NL)

Thumbnail

Prevalence of patients with paroxysmal supraventricular tachycardia (PSVT) in the United States

Speaker: Doctor D. Wood (Chapel Hill, US)

Thumbnail

Association of minority status with mortality and hospital readmission in patients with ischemic cardiomyopathy in the STICH trial

Speaker: Professor D. Brown (St Louis, US)

Thumbnail

Research network in Africa (RNA): observatory of hospitalizations in cardiology departments in 14 African countries (FEBRUARY Study: 2016, 2017 and 2018)

Speaker: Professor I. Diop (Dakar, SN)

Thumbnail

Stroke and death in atrial fibrillation patients newly treated by oral anticoagulants in France: a national cohort study 2012-2016

Speaker: Ms A. Gabet (Saint Maurice, FR)

Thumbnail

Access the full session

Poster Session 4 - Cardiovascular epidemiology and trials

Speakers: Professor M. Imazio, Associate Professor M. Kavousi, Doctor D. Wood, Professor D. Brown, Professor I. Diop...
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk